Evidence map›Paper›PMID 41481015›Full record

ArticleVaccine2025

Emergence of non-vaccine Streptococcus pneumoniae serotypes colonizing the nasopharynx of children under five years of age in the 13-valent pneumococcal conjugate vaccine era in Tanzania. A short communication.

James Samwel Ngocho, Christa E van der Gaast-de Jongh, Julieth Sebba, Monica Mtei, Grace Kinabo, Blandina T Mmbaga, Marien I de Jonge

Abstract readCorrected and Republished Article
In one paragraph

Article in Vaccine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

James Samwel NgochoDepartment of Epidemiology and Applied Biostatistics, Kilimanjaro Christian Medical University College, Moshi, Tanzania; Duke Global Health Institute, Duke University, 310 Trent Drive, Durham, NC 27710, USA. Electronic address: james.ngocho@kcmcu.ac.tz.
Christa E van der Gaast-de JonghDepartment of Laboratory Medicine, Laboratory of Medical Immunology, Radboud Community for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Julieth SebbaDepartment of Community Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Monica MteiDepartment of Epidemiology and Applied Biostatistics, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Grace KinaboDepartment of Pediatric and Child Health, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Blandina T MmbagaDuke Global Health Institute, Duke University, 310 Trent Drive, Durham, NC 27710, USA; Department of Pediatric and Child Health, Kilimanjaro Christian Medical University College, Moshi, Tanzania; Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
Marien I de JongeDepartment of Laboratory Medicine, Laboratory of Medical Immunology, Radboud Community for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.

Funding

Strengthening of Research Capacity for Junior Faculty in TanzaniaD43TW010138 · FIC · KILIMANJARO CHRISTIAN MEDICAL COLLEGE · PI MTETA, ALFRED KIEN · 2015 to 2020
$3.2M
Clinical decision support algorithm to optimize management of respiratory tract infection in children attending primary health facilities in Kilimanjaro Region, TanzaniaK43TW012585 · FIC · KILIMANJARO CHRISTIAN MEDICAL CENTRE · PI James Samwel Ngocho · 2023 to 2026
$339k
FIC NIH HHS D43 TW010138FIC NIH HHS K43 TW012585
6 · The paper itself

Abstract

To determine the impact of pneumococcal vaccination on nasopharyngeal carriage in Tanzania, we assessed the serotype distribution of S. pneumoniae isolated from nasopharyngeal swab samples. These samples were collected in 539 children below the age of 5 years in two cross-sectional studies, one before and one after PCV13 rollout. In the second study, post-PCV13 rollout, only children who completed the PCV13 vaccination schedule, were included. From the study conducted before the introduction of PCV13, 61 (55 %) of S. pneumoniae serotypes were vaccine types, compared to 89 (23.3 %) post-PCV13. The most common serotypes in the pre-PCV13 period were 19F (n = 23, 20.7 %) and 6B (n = 11, 9.9 %). In the post-PCV13 era, serotypes 15B/C (n = 40, 10.5 %), and 3 (n = 29, 7.6 %) were most prevalent. We observed the emergence of 14 non-vaccine serotypes not detected in the pre-vaccine era. Further surveillance is needed to assess shifts in carriage and their implications for the protection against invasive pneumococcal disease.

Indexed as

13-valent pneumococcal conjugate vaccineChildren under the age of five yearsColonizationStreptococcus pneumoniaeTanzania

Identifiers

PMID41481015
PMCPMC12780951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.